Motion-Secondary: ROBERT ROSS et al VS. C.C. MOORE & CO. ENGINEERS

• 
• 
• 
• 
• 
• 
• 
• 

						
                                
Preview
                                Hake Law
A PROPESSIONAL CORPORATION

wv

ELECTRONICALLY

William M. Hake, Esq. (State Bar No. 110956) F I L E D |
Melissa Ippolito, Esq. (State Bar No. 239811) Superior Courtlof California,
Kathryn L. Hoff, Esq. (State Bar No. 260420) . County of Sar Francisco
HAKE LAW, A PROFESSIONAL CORPORATION FEB 22'2013
655 Montgomery Street, Suite 1000
San Francisco, CA 94111 oclork of the Court
Tel: 415-926-5800

Deputy Clerk

Fax: 415-926-5801
bill@hakelaw.com
melissa@hakelaw.com
iucy@hakelaw.com

Attomeys for Defendants

COLLINS ELECTRICAL COMPANY, INC.; EMIL J. WEBER ELECTRIC CO.,;
BELL PRODUCTS, INC.; ADVANCE MECHANICAL CONTRACTORS;

BRAGG INVESTMENT COMPANY, INC.; ANDERSON, ROWE, BUCKLEY, INC.

IN THE SUPERIOR COURT OF THE STATE OF CALIFORNIA
COUNTY OF SAN FRANCISCO
ROBERT ROSS AND JEAN ROSS, | Case No.: CGC-10-275731
Plaintiffs, DECLARATION OF KHALIL SHEIBANIL,
M.D. IN SUPPORT OF MOTION FOR
vs. SUMMARY JUDGMENT

C.C. MOORE & CO., ENGINEERS, et al., Complaint: December 17, 2010
Trial Date: June 10, 2613

Defendants, |

}, Khalil Sheibani, M.D., declare as follows:
1. have personal knowledge of each fact set forth in this Declaration and, if called upon to

testify, could and would competently testify thereto.

w

jam a medica! doctor and have an active license to practice medicine in the State of
California. Iam board certified in Anatomical Pathology, Clinical Pathology, and
Immunopathology. I was head of the Division of Hematopathology and
Immunopathology and Director of Oncologic Hematopathology Fellowship Training
Program at, Department of Pathology, City of Hope/Beckman Research Institute, { held
an academic position at the Department of Pathology, University of Southern California,
from [990 to 2012 as a Clinical Professor of Pathology. Currently, I am a Pathologist
and Director of Hematology and Immunchematology Laboratory at Western Medical

ATION OF RHATIC’HAKE Law
4 PROFESSIONAL CORPORATION

we

aD

[ BECEARATION OF 1

Center in Santa Ana, California. I am also the Director of Anatomic and Clinical
Pathology at Westem Medical Center in Anaheim, California. [ have extensive
knowledge and experience in the diagnosis and study of pathology of malignant and
benign diseases caused by asbestos. I have published approximately 200 peer review
articles, book chapters, editorials, and abstracts on different issues in the field of
pathology, primary oncologic pathology, including asbestos-related tumors and disorders,
As my CV indicates, I have been the recipient of a total of nine (9) National Institute of
Health (NIH) National Institute of Cancer (NCI) Scientific Grants and Institutional.
Scientific Grants as Principal or co-investigator; all dealing with the study and research
of human malignant oncologic diseases. I have been on Editorial Boards of National and
Intemational Scientific Journals. In 1986, my research in oncologic pathology resulted inj
the discovery of a previously unrecognized malignant tumor for which the patients now
are receiving proper treatment (Am J Pathol (986, 124:310-318). My work in
Immunopathology resulted in characterization of antigens now commonly used
worldwide for the diagnosis of asbestos-related malignancies (Am J Surg Pathol
10(4):227-236, 1986; Am J Pathol 123:212-219, 1986; Am J Surg Pathol 15(8):779-784,

1991}, Attached as Exhibit A is a true and correct copy of my Curriculum Vitae.

. T have reviewed medical records and pathology materials of Plaintiff Robert Ross in

consultation, The pathology includes twenty-eight (28) slides, which [ received from
Carondelet St. Joseph’s Hospital on March 8, 2011.. These slides were prepared from a
biopsy of the sigmoid mass in Mr. Ross’ colou on October 26, 2010 and a resection of
Mr. Ross’ colon and rectum on November 8, 2010. From my review of the twenty-eight
(28) slides, I confirmed the diagnosis of invasive adenocarcinoma of the colon, which

had originated from a pre-existing benign polyp.

. Polyps are benign lesions that may occur in human colorectal areas. The progression of

benign colorectal polyps to carcinoma in-situ and eventually adenocarcinoma is a well-
known phenomenon. The data to support the polyp-cancer sequence come from both

epidemiologic and pathologic studies. Countries with low rates of colorectal cancer alsoHAKE LAW
A PROFESSIONAL CORPORATION

have low rates of polyps. Whereas, countries with high rates of colorecial cancer have a
high incidence of polyps (Diagnostic Surgical Pathology, S. Sternberg, 2nd edition, 1994:
p.1381). To my knowledge, there is no causal relationship between colorectal polyps and|
asbestos exposure, and there is no increased risk of colorectal polyps in individuals who

have been exposed to asbestos.

. I performed iron staining on fourteen (14) out of the twenty-cight (28) slides trom Me.

Ross’ sigmoid mass and colorectal resection. Iron staining is a procedure by which
pathologists can determine the presence or absence of asbestos bodies in the specimen
reviewed, According to the criteria published by the College of American Pathologists
(CAP) and Pulmonary Pathology Society, one needs to identify sufficient number of
asbestos bodies in lung tissue to establish the causal relationship between lung cancer and!
asbestos (Arch Pathol Lab Med-Vol 134, March 2010), Therefore, it is scientifically
reasonable to apply the same concept to the extrapulmonary cancers, including colorectal
carcinoma. | found no asbestos bodies in iron-stained histologic sections prepared from

Mr. Ross' colon tissue.

. Based on the established scientific facts in medical literature, my own experience and

research in the field of oncologic pathology, and objective pathologic findings in the
histologic sections prepared from Mr. Ross’ colon tissue that showed transformation of
benign polyp to cancer, as well as the absence of asbestos bodies in special stain studies
performed on his colon tissue, it is my opinion to a reasonable degree of medical
certainty that Mr. Ross’ colon cancer originated from a pre-existing polyp. Therefore, the
polyp should be considered the cause of this patient's colon cancer. As such, to a
reasonable degree of medical probability, the cause of Mr. Ross’ colon cancer is
unrelated to any alleged asbestos exposure.

1 declare under penalty of perjury under the laws of the State of California that the

&
foregoing is true and correct. Executed on February 19, 2013 at Sande Ana. a .

.

Khalil Sheibani, MD.

‘GF KHALIL SHENBART.Exhibit A
to the Declaration of
Khalil Sheibani, M.D.Khalil Sheibani, M.D.
CURRICULUM VITAE
A. PERSONAL INFORMATION
NAME: Khalil K. Sheibani, M.D.
CITIZENSHIP: U.S.
BUSINESS ADDRESS: Western Medical Center
Department of Pathology
1001 N. Tustin Avenue
Santa Ana, California 92705
Ph: (714) 953-3380
FAX: (714) 953-3542
HOME ADDRESS: One Island Vista
Newport Coast, California 92657
(945) 706-7818
EMAIL: ksheibani@hotmail.com
PLACE OF BIRTH: Tabriz, Iran
MARITAL STATUS: Married, three children
B. BOARD CERTIFICATIONS:
Diplomat, American Board of Pathology, Immunopathology, 1985

Diplomat, American Board of Pathology,

1980

Clinical Pathology,

Diplomat, American Board of Pathology, Anatomic Pathology,

1978

C. MEDICAL LICENSE:

Ohio 1980

California 1981

D. EDUCATION:

Special Fellow, Department of Immunopathology,

Division of

Pathology and Laboratory Medicine, Cleveland Clinic
Foundation (with Sherad Deodhar, M.D., Ph.D.}, 1980-1981
Resident, Department of Clinical Pathology, Division of
Pathology and Laboratory Medicine, Cleveland Clinic
Foundation, 1978-1980

Resident, Department of Anatomic Pathology, Division of
Pathology and Laboratory Medicine, Cleveland Clinic
Foundation, 1975-1978Khalil Sheibani, M.D.

EDUCATION, CONTINUED:
Resident, Department of Anatomic Pathology, Tabriz University
Medical School, Department of Laboratory Medicine, 1972-1975
Internship, Tabriz University Medical School, 1971-1972
M.D., Tabriz University Medical School, Tabriz, Iran, 1970
E. ACADEMIC APPOINTMENTS

Clinical Professor of Pathology, Department of Pathology,
University of Southern California, Los Angeles, California,
1990 - present

Professor of Pathology, City of Hope Medical Center, March
1990 - July 1990

Associate Professor of Pathology, City of Hope Medical
Center, March 1985 - March 1990

Assistant Professor of Pathology, City of Hope Medical
Center, October 1981 - March 1985

F. PROFESSIONAL APPOINTMENTS:

Director of Pathology Laboratory, Department of Surgery,
Western Medical Center, Anaheim, January 1999 - present

Consultant Pathologist, Oncotech, September 1992-present.

Pathologist, Department of Pathology, Western Medical Center
Santa Ana, California, July 1390- present

Pathologist, Pathology Laboratory, Western Medical Center
Anaheim, California, July 1990- present

Director of Hematology and Immunohematology, Department of
Pathology, Western Medical Center, Santa Ana, California,
Jaly 1990 ~ present

Clinical Professor of Pathology, Department of pathology,
University of Southern California (1990 - 2012

Senior Consultant, Department of Pathology, City of Hope,
July 1990 - December 1997

Pathologist, Division of Pathology, City of Hope National
Medical Center, Duarte, California, October 1981 - duly 1990Khalil Sheibani, M.D.

Director of Hematopathology, Division of Pathology, City of
Hope National Medical Center, Duarte, California, July 1987-

July 1990

Director of Hematopathology Fellowship Training Program, City
of Hope National Medical Center, Duarte, California, July

1987-July 1990
G. PAST AND PRESENT PROFESSIONAL SOCIETY MEMBERSHIPS:

International Academy of Pathologists

The American Association of Pathologists
American Society of Hematology

The College of American Pathologists

Society of Hematopathology

Los Angeles Society of Pathologists

City of Hope Cancer Research Center

American Society of Clinical Pathologists
American Association for Cancer Research
American Association for Advancement of Science

H. EDITORIAL MEMBERSHIPS:
Editorial Board, Human Pathology (1990-present).
Editorial Board, Leukemia and Lymphoma, Harwood Academic
Publisher (1989-1991).
I. AWARDS AND GRANTS:
A. AWARDS:
1. Physician of the Month, February 2003, Tenet Health
Network, Western Medical Center, Santa Ana.

2. Physician of the Year, 2003, Tenet Health Network,
Western Medical Center, Santa Ana.

B. CLINICAL RESEARCH GRANTS:

Principal Investigator

1. immunohistologic Evaluation of Lymphoproliferative
Disorders (City of Hope National Medical Center)
(1982-1983)

2.  Clinico~biologic Correlation in Lymphoma and Leukemia

(SROICA 26422-04) (1987-1988Khalil Sheibani, M.D.

Co~Investigator

i.

The Study of Cytogenesis of B-cell Lymphomas; Cleveland
Clinic Foundation (CRP#457 with Dr. Raymond Tubbs}
(1978-1980)

American Cancer Society for Clinical Fellowship (CF
#5187 with Dr. Henry Rappaport) (1983~1988)

Neoplastic Hematopathology Grant (5-T32-CA08308-05 with
Dr. Henry Rappaport) (1983-1988)

Pathology Center for Lymphoma Clinical Studies Grant
{R1LOCA180044~-08 with Dr. Henry Rappaport) (1985-1988)

Monoclonal Antibody in the Immunohistochemical
Classification of Solid Tumors (1 RO1 CA37194~O01Al with
Dr. Hector Battifora) (1983-1990)

Preoperative Cancer Radioimmuncimaging with INDACEA
(LROL CA42329-01 with Dr. David Beatty) (1986-1988) .

The role of CMV in the Acquired Immunodeficiency
Syndrome (5-U01-CA-34991 with Dr. John Zaia) (1983-1985).

Analysis of Tumor DNA Contents (NCI with Dr. William
Kokal) (1985-1990).

Analysis of MDR-1 expression in ovarian carcinoma. NCI
SBIR Grant (with Dr. John Fruehauf) {Submitted in
October 1993)

J. INVITED REVIEWER FOR PATHOLOGY AND MEDICAL JOURNALS:

American Journal of Pathology.

Cancer.

Archives of Dermatology.

Laboratory Investigation.

Human Pathology.

Archives of Pathology and Laboratory Medicine

K. PAST AND PRESENT COMMITTEE MEMBERSHIPS:

Chairman, Infection Control Committee, City of Hope National
Medical Center.Chairman,
Center,

Khalil Sheibani, M.D.

tissue Committee, City of Hope National Medical

Infection Control Committee, Western Medical Center/Anaheim.

PAST AND PRESENT COMMITTEE MEMBERSHIPS, CONTINUED:

Quality Assurance Committee, Western Medical Center/Anaheim.

Department
Anaheim.

of Surgery Committee, Western Medical Center/

Medical Executive Committee, Western Medical Center/Anaheim

Credentials Committee, Western Medical Center/Anaheim

Chairman,
Hospital.

Infection Control Committee, Tustin Rehabilitation

Medical Executive Committee, Tustin Rehabilitation Hospital.

L. PRESENTATIONS:

1.

Immunofluorescence of necropsy kidney tissue: A
reliable technique. Fall Meeting of American
Society of Clinical Pathologists, September, 1978,
St. Louis, Missouri

Pathologic aspects of acute leukemia arising during
immunosuppressive therapy for inflammatory disease.
American Society of Clinical Pathologists, 1978,
St. Louis, Missouri

Malignant histiocytosis: Immunocytochemical and
ultrastructural characteristics. Annual Meeting of
International Academy of Pathology, March, 1973,
San Francisco, California

Immunocytochemical identification of human
chorionic gonadotropin (HCG). Comparative
evaluation of diaminobenzidine and non-hazardous
chromogen. Annual Meeting of International Academy
of Pathology, March, 1979, San Francisco,
California

Expression of monocytic/histiocytic cytochemical
510.

il.

12.

13.

Khalil Sheibani, M.D.

markers in epithelial neoplasia. Spring Meeting of
American Society of Clinical Pathologists, March,
1979, New Orleans, Louisiana

Giant cell myocarditis: Immunocytochemical and
morphological evidence for myocardial origin of
characteristic cell. Spring Meeting of American

Society of Clinical Pathologists, March, 1979, New
Orleans, Louisiana

Leukemia occurring in treated Hodgkin's disease.
Two neoplasms or one? Sequential cytochemical and
immunologic evaluation of a case. Fall Meeting of
American Society of Clinical Pathologists, October,
1979, Las Vegas, Nevada

Alternate chromogens as substitute for benzidine
for myeloperoxidase cytochemistry. Spring Meeting
of American Society of Clinical Pathologists,
March, 1980, New Orleans, Louisiana

Frozen section immunocytochemistry of malignant
lymphomas using the direct immunoperoxidase
methods. Annual Meeting of International Academy
of Pathology, March, 1980, New Orleans, Louisiana

Comparison of alternate chromogens for renal
immunohistochemistry. Annual Meeting of
International Academy of Pathologists, March, 1980,
New Orleans, Louisiana

Tissue immunomicroscopy versus cell suspensions.
Fall Meeting of American Society of Clinical
Pathologists, 1980, St. Louis, Missouri

Reactive lymphoid hyperplasia and non-Hodgkin's
lymphoma - The role of immanohistochemistry. Fall
Meeting of American Society of Clinical
Pathologists, 1980, St. Louis, Missouri

Comparison of alternate chromogens in cytochemistry
of leukemias. Annual Meeting of International
Academy of Hematology, August, 1980, Montreal,
Canada14.

15.

16.

LT.

18.

19.

20.

21.

22.

Khalil Sheibani, M.D.

Reactive lymphoid hyperplasia vs. non-Hodgkin's
lymphoma - A simple test to make the distinction.
The 18th Congress of the International Society of
Hematology, 1980, Montreal, Canada

Immunomicroscopy of Warthon's tumor. Spring
meeting of American Society of Clinical
Pathologists, March, 1981, San Diego, California

Enzyme labeled immunohistochemistry: Technical
aspects and diagnostic applications. Seminar in
immunology, Cleveland Clinic Foundation, April,
1981, Application of Immunohistochemistry to
Surgical Pathology

Characterization of blood mononuclear and cultured
cells in hairy cell leukemia. American Society of
Clinical Pathologists, March, 1981, New Orleans,
Louisiana

Immunologic quantitation of serum-C-reactive
protein. International Academy of Pathologists,
March, 1981, Boston, Massachusetts

Application of the fluorescence activated cell
sorter (FACS II) to the study of normal human
T-cell subsets. Spring Meeting of International
Academy of Pathology, 1982, Boston, Massachusetts

Cytochemical and ultrastructural studies on human
T-cell subsets separated with the fluorescence
activated cell sorter (FACS II). Fall Meeting of
the American Society of Clinical Pathologists,
1982, Miami Beach, Florida

A monoclonal antibody to keratin to distinguish
anaphilic seminoma from embryonal carcinoma.
Spring Meeting of International Academy of
Pathology, 1983, Atlanta, Georgia

Monocytoid cells in reactive follicular
hyperplasia: Immunohistochemical study of 21
cases. Spring Meeting of International Academy of
Pathology, 1984, San Francisco, California23.

24.

25.

26.

27.

28.

29,

30.

31.

Khalil Sheibani, M.D.

Does determination of the Leu-3a/Leu-2a ratio aid
in the early diagnosis of mycosis fungoides in
lymph nodes with dermatopathic lymphadenopathy?
Spring Meeting of International Academy of
Pathology, 1985, Toronto, Canada

Immunologic characterization of 35 cases of
gastrointestinal lymphomas. Spring Meeting of
International Academy of Pathology, 1985, Toronto
Canada

Monocytoid B lymphocytes in AIDS-related
lymphadenopathy. Spring Meeting of International
Academy of Pathology, 1985, Toronto, Canada

Antigenic phenotype of malignant mesotheliomas.
Spring Meeting of International Academy of
Pathology, 1986, New Orleans, Louisiana

A systematic approach for immunohistologic
classification of lymphoproliferative disorders.
Spring Meeting of International Academy of
Pathology, 1986, New Orleans, Louisiana

Angiotropic (intravascular) large cell lymphoma,
so-called "malignant angioendotheliosis." Spring
Meeting of International Academy of Pathology,
1986, New Orleans, Louisiana

Monocytoid B-cell lymphoma: A novel B-cell
neoplasm. Los Angeles Society of Pathologists,
1986, Los Angeles, California

Differentiation between small noncleaved cell and

Lymphoblastic lymphomas: A study of
paraffin-embedded fixed tissue sections using
monoclonal antibodies. Spring Meeting of

International Academy of Pathology, 1987, Chicago,
Illinois

Reactive and neoplastic monocytoid B lymphocytes
share immunophenotypic characteristics with hairy
cell leukemia. Spring Meeting of International
Academy of Pathology, 1987, Chicago, Illinois32.

33.

34.

35.

36.

37.

38.

39.

Khalil Sheibani, M.D.

Antigenic phenotype of the lymphocytic component of
medullary carcinoma of the breast. Spring Meeting
of International Academy of Pathology, 1987,
Chicago, Illinois

A practical approach to the immunogenetic analysis
of lymphoproliferative disorders. Spring Meeting
of International Academy of Pathology, 1987,
Chicago, Illinois

Peripheral T celi lymphomas: Morphologic and
immunologic differential diagnosis based on the
evaluation of 502 cases. Spring Meeting of

International Academy of Pathology, 1987, Chicago,
Tlilinois

Distribution of lymphocytes with interleukin 2
receptors (TAC antigens) in reactive
iymphoproliferative processes, Hodgkin's disease,
and non-Hodgkin's lymphomas: An immunchistologic
study of 300 cases. Spring Meeting of
International Academy of Pathology, 1987, Chicago,
Illinois

Antigenically defined subgroups of lymphoblastic
Lymphoma: Their relationship to clinical
presentation and biologic behavior. Spring Meeting
of International Academy of Pathology, 1987,
Chicago, Illinois

The immunoarchitecture of the "pseudofollicles" of
well differentiated lymphocytic lymphoma: A
comparison with true follicles. Spring Meeting of
International Academy of Pathology, 1987, Chicago,
Tllinois

Variability in interpretation of immunohistologic
findings of lymphoproliferative disorders by
hematopathologists: A comprehensive statistical
analysis of interobserver performance. Spring
Meeting of International Academy of Pathology,
1987, Chicago, Illinois

Monocytoid B cell lymphoma: Clinicopathologic
study of 21 cases of a unique type of low grade
lymphoma. Spring Meeting of International Academy
of Pathology, 1988, Washington, D.c.40.

41.

42.

43.

44.

45.

46.

47,

Khalil Sheibani, M.D.

Absence of clonal lymphoid gene rearrangements in
hashimoto's thyroiditis. Spring Meeting of
International Academy of Pathology, 1988,
Washington, D.C.

Multidisciplinary studies of lymphoproliferative
disorders: A comparison of frozen tissue and cell
suspension immunologic studies based on the
evaluation of 612 consecutive cases. Spring
Meeting of International Academy of Pathology,
1988, Washington, D.C.

Further evidence demonstrating the value of Leu-Ml
antigen in differential diagnosis of malignant
mesothelioma and adenocarcinoma: An
immunohistologic evaluation of 395 cases. Spring
Meeting of International Academy of Pathology

1988, Washington, D.C.

Surface immunoglobulin {SIg) positive, Tat
negative, lymphoblastic lymphoma: A report of
three cases. Spring Meeting of International

Academy of Pathology, 1988, Washington, D.C.

Angiotrophic large cell Lymphoma (malignant
angioendotheliomatosis}: Report of three cases
with unique clinical presentation. Spring Meeting

of International Academy of Pathology, 1988,
Washington, D.C.

Splenic involvement by aggressive malignant
lymphoma of B- and T-cell types: A morphologic and
immunophenotypic study. Spring Meeting of
International Academy of Pathology, 1988,
Washington, D.C.

Peripheral T-cell lymphomas resembling unusual
variants of B-cell lymphoma. Spring Meeting of
International Acadeny of Pathology, 1988,
Washington, D.C.

Epidemiologic expression of Hodgkin's disease in
Los Angeles County. Spring Meeting of
International Academy of Pathology, 1988,
Washington, D.C.4g.

4g.

50.

Si.

52.

53.

34.

55.

56.

Khalil Sheibani, M.D.

Antigenic phenotype of histiocytosis X cells: An
immunohistochemical study demonstrating the value
of LN-2, LN-3, and vimentin. Spring Meeting of
International Academy of Pathology, 1983,
Washington, D.C.

Keratin-like immunoreactivity in lelomyosarcomas,
uterine leiomyomas, and normal myometrium by
Academy of Pathology, 1988, Washington, D.C.

Monocytoid B-cell lymphoma: its evolution and
distinction from hairy cell leukemia and other low
grade B-cell neoplasms. Leukemia Society

Symposium, 1988, New Orleans, Louisiana

Monocytoid B-cell Lymphoma: Its common association
and relationship to Sjogren's Syndrome. Fall
Meeting of XVII International Congress in Dublin,
Ireland

Significant change in the ratio of kappa and lambda
light chains in human malignant lymphoproliferative
disorders. Fall Meeting of XVII International
Congress in Dublin, Ireland

Analysis of Ha-ras sequence in DNAs of malignant
mesothelioma and pulmonary adenocarcinoma by a
sensitive polymerase chain reaction (PCR) method.
Spring Meeting of International Academy of
Pathology, 1989, San Francisco, California

fumor DNA content, the single most important
prognostic parameter in resectable primary
colorectal adenocarcinoma. Spring Meeting of
International Academy of Pathology, 1989, San
Francisco, California

Tumor DNA content as a prognostic indicator in
squamous cell carcinoma of the head and neck
region. Spring Meeting of International Academy of
Pathology, 1989, San Francisco, California

Further evidence that "plasmacytoid T cell lymphoma
associated with chronic myeloproliferative
disorder" is of macrophage/mononuclear ceil origin.
Spring Meeting of International Academy of
Pathology, 1989, San Francisco, California57.

58.

59.

60.

61.

62.

63.

64.

65.

Khalil Sheibani, M.D.

Pathology panel and repository center for lymphoma
clinical studies: Summary of 20 years experience
in the quality control of histopathologic
interpretation. Spring Meeting of International
Academy of Pathology, 1983, San Francisco,
California

Monocytoid B-cell lymphoma: review of
pathologic and clinical aspects. University
of California, Los Angeles, UCAL Department of
Pathology, Grand Round, Guest Speaker,
December 1989

Monocytoid B-cell lymphoma in patients with
Sjogren's syndrome: Clinicopathologic study of
twelve patients. Spring Meeting of International
Academy of Pathology, 1990, Boston, Massachusetts

Molecular biology of monocytoid B-cell lymphoma:
Absence of HTLV-I, HTLV-II, and HIV genome and
rearranged bcl-2 genes in neoplastic monocytoid
B-celis. Spring Meeting of International Academy
of Pathology, 1990, Boston, Massachusetts

Hairy-cell leukemia and monocytoid B-cell lymphoma:
An immunohistologic comparison of 56 cases. Spring
Meeting of International Academy of Pathology,
1990, Boston, Massachusetts

True histiocytic lymphoma: An analysis of eight
cases with multiparameter studies. Spring Meeting
of International Academy of Pathology, 1990,
Boston, Massachusetts

Progression of monocytoid B-cell lymphoma to large
cell lymphoma: Report of six cases. Spring
Meeting of International Academy of Pathology,
1990, Boston, Massachusetts

Angiotropic large cell lymphoma: Clinicopathologic
study of seven cases with unique clinical
presentations. Spring Meeting of International
Academy of Pathology, 1990, Boston, Massachusetts

Granulocytic sarcoma simulating Lymphoblastic
lymphoma: A report of two cases. Spring Meeting

1266.

67.

68.

69.

70.

Ti.

72.

73.

74.

Khalil Sheibani, M.p.

ef International Academy of Pathology, 1990,
Boston, Massachusetts

Effect of tissue fixation in ploidy analyses.
Spring Meeting of International Academy of
Pathology, 1990, Boston, Massachusetts

Antigenic phenotype of large cell lymphoma: An
immunchistologic study of 248 cases on
paraffin-embedded, fixed tissue sections. Spring

Meeting of International Academy of Pathology,
1990, Boston, Massachusetts

Malignant histiocytosis X- a distinct
clinicopathologic entity. Spring Meeting of
International Academy of Pathology, 19930, Boston,
Massachusetts

Immunoarchitecture of normal human bone marrow.
Spring Meeting of International Academy of
Pathology, 1990, Boston, Massachusetts

A novel biotinylated probe specific for
hyaluronate: Its diagnostic value in malignant
mesothelioma. Spring Meeting of International
Academy of Pathology, 1990, Boston, Massachusetts

Epidemiological study of HIV-negative and
HIV-positive intermediate and high grade B-cell
lymphomas: Cytogenetic correlations. May 1990

Malignant Mesothelioma; Review of Pathologic
and Immunopathologic features. Western Medical
Center, Santa Ana, California, 1990

Shin SS, Sheibani K, Kezirian J, Weiss LM: The
Ber~EP4 antibody as a discriminant in the
differential diagnosis of mesothelioma versus
adenocarcinoma. (United States and Canadian Academy
of Pathology 1991, Chicago)

Shin SS, Ben-Ezra J, Sheibani K, Rappaport H:

Reed-Sternberg-like cells in low grade lymphomas
are transformed neoplastic cells of B-cell
lineage. (United States and Canadian Academy of
Pathology 1991, Chicago)

75.

Kezirian J, Shin SS, Joyce, d, Stroup, RM, Ben-
Ezra,J, Traweek ST, Esteban JM, Koo CH, Sheibani K:
1376.

TT,

738.

79,

80.

81.

82.

83.

84.

85.

Khalil Sheibani, M.D.

Effects of fixation on the preservation of
hematopoietic-associated antigens. Comparison of
five fixatives (United States and Canadian Academy
of Pathology 1991, Chicago)

Immunopathology of Human Immune Deficiency
Syndrome. Symposium on HIV-related Disorders.
Western Medical Center, Santa Ana, California
September 1991

Monocytoid B-cell lymphoma: pathologic, biologic
and clinical features. University of Southern
California (USC), Los Angeles, California,
Department of Pathology, Grand Round. June 1992

Malignant mesothelioma: pathologic,
immunologic, biologic, and clinical features.
University of Southern California (USC), Los
Angeles, California, Department of Pathology,
Grand Round. June 1993

Hematolymphoid Disorders in patient's with
Immune Deficiency. Western Medical Center, Santa
Ana, California, 1997

Pathology of Asbestos-Related Disorders: Symposium
in Asbestos~related disorders. Oakland,
California, October 1994

Role of Immunopathology in Diagnostic Surgical
Pathology. Western Medical Center, Santa Ana,
California, 1998

Pathology of Asbestos-Related Disorders: Symposium
In Asbestos-related disorders.Oakland, California,
1998

Surgical Pathology and Tmmunopathology of
Neoplastic Disorders of Serosal Membranes; pleura,
pericardium, and peritoneum. Invited Speaker
University of Southern California, School of
Medicine, Department of Pathology, March 18,2001

Immunopathology of Malignant Mesothelioma (MM) and
pulmonary Adenocarcinoma (PAC). Spring Meeting of
tnternational Academy of Pathology, March 2001.
Atlanta, Georgia

Simian Virus 40 DNA Sequences are not common in
Human Malignant Mesothelioma. A PCR analysis using

i4Khalil Sheibani, M.D.

paraffin tissues. Spring Meeting of International
Academy of Pathology. March 2001, Atlanta, Georgia

86. Marginal Zone Lymphoma/Monocytoid 8-cell Lymphoma.
Western Medical Center, Santa Ana, California,
2002,

87, Simian Virus 40 DNA Sequences are uncommon in Human
Malignant Mesothelioma. A PCR analysis of 89 cases
using paraffin tissues. International Academy of
Pathology, March 2003, Washington, DC

88. Her-2/neu gene amplification is uncommon in human
malignant mesotheliomas. A Chromogenic In Situ
Hybridization Assay {(CISH) using tissue Microassay.
International Academy of Pathology,

March 2004, Vancouver, Canada

89. p53 is a useful marker in distinguishing pleural
malignant mesothelioma (PMM) from pulmonary
squamous cell carcinoma (SCC). United States and
Canadian Academy of Pathology. March 2005, San
Antonio, Texas

90. CD138 is not a helpful marker in distinguishing
spindle cell adenocarcinoma (SCA) from malignant
mesothelioma (MM): A paraffin immunohistochemical
study. United States and Canadian Academy of
Pathology. March 2005, San Antonio, Texas

91. Epidermal growth factor xeceptor (EGFR) gene
amplification in pleural malignant
mesothelioma (MM) : A chromogenic in situ
hybridization (CISH} assay. United States and
Canadian Academy of Pathology. March 2005, San
Antonio, Texas.

M, BIBLIOGRAPHY:

rT.

L

SCIENTIFIC PAPERS:

Sheibani K, Tubbs RR, Savage RA, Sebek BA: Fibrillary
inclusions. Hum Pathol 9:608-609, 1978

Tubbs RR, Sheibani K, Savage RA, Sebek BA: Value of
cytochemistry in diagnosis of malignant histiocytosis.
Hum Pathol 10:483, 1979

Sheibani K, Tubbs RR, Savage RA, Sebek BA, Valenzuela R,
Hewlett JS: Leukemia occurring in treated Hodgkin's
1510.

il.

12.

13.

Khalil Sheibani, M.D.

disease. Two neoplasms or one? Sequential cytochemical
and immunologic evaluation of a casé. Cleveland Clinic 0
46:39-47, 1979

Sheibani__K, Tubbs RR, Valenzuela R, Deodhar Sr
Reliability of immunofluorescence performed on autopsy
kidney tissue. Am Jd Clin Pathol 72:222-24, 1979

Maleki M, Flesher B, Schkar E, Sheibani K: Achalasia
secondary to carcinoma of stomach. Cleveland Clinic 9
46:137-147, 1979

Sheibani K, Bukowski R, Tubbs RR, Savage RA, Sebek BA,
Hoffman GC: Acute non-lymphocytic leukemia in patients
receiving chemotherapy for non-malignant diseases. Hum
Pathol 11:175-179, 1980

Tubbs RR, Sheibani_ K, Sebek BA, Savage RA: Malignant
histiocytosis-ultrastructural and immunocytochemical
characterization. Arch Pathol Lab Med 104:26-29, 1980

Tubbs RR, Sheibani K, Hawk WA: Giant cell myocarditis.
Ultrastructural and immunocytochemical evidence for
myocardial origin of the characteristic cell. Arch
Pathol Lab Med 104:245-246, 1980

Tubbs RR, Sheibani K, Weis R, Sebek BA:
Immuno fluorescence versus immunocytochemistry in
diagnosis of non-Hodgkin's lymphoma (NHL). Am ¢d Clin
Pathol 73:144~-145, 1980

Tubbs RR, Sheibani K, Weis R, Sebek BA: Reactive
lymphoid hyperplasia versus non-Hodgkin's lymphoma:
Role of tissue immunomicroscopy. Am J Clin Pathol

74:501, 1980

Tubbs RR, Sheibani K, Weis R, Lee V, Sebek BA:
Immunocytochemistry of Warthon's tumor. Am J Clin
Pathol 74:795-797, 1980

Sheibani_K, Tubbs RR, Gephardt GN, McMahon JT,
Valenzuela R: Comparison of alternate chromogens for
renal immunohistochemistry. Hum Pathol 12:349-354, 1981

Sheibani_ K, Lucas FV, Tubbs RR, Savage RS, Hoeltchi GA,

Tubbs RR: Alternate chromogens as substitutes for

benzidine for myelosuppresssion cytochemistry. Am J
1614.

1s.

16.

17.

18.

is.

20.

2k.

22.

23.

Khalil Sheibani, M.D.
Clin Pathol 75:367-370, 1982

Tubbs RR, Sheibani K, Weiss R, Sebek BA: Frozen section
immunchistochemistry of fresh-frozen lymphoid tissue
with the direct immunoperoxidase technique. Am J Clin
Pathol 75:172-174, 1981

Tubbs RR, Sheibani_K, Deodhar SD, Hawk, WA: Enzyme
immunohistochemistry: Review of technical aspects and
diagnostic applications. Cleve Clin Q 48:245+281, 1981

Tubbs RR, Sheibani K: Chromogens for
immunocytochemistry. J Histochem 29:684, 1981

Tubbs RR, Sheibani K, Weis R, Sebek, BA: Tissue
immunomicroscopic evaluation of monoclonality of B cell
lymphomas. Comparison with cell suspension studies. Am

J Clin Pathol 76:24-28, 1981

Tubbs RR, Sheibani_K: Immunchistechemical techniques
and chromogens. Arch Pathol Lab Med 106:205, 1982

Gransar A, Sheibani K, Barna B, Savage R, Valenzuela R,
McMahon J, Deodhar S$: Characterization of cultured
cells in hairy cell leukemia. Am J Clin Pathol
79:733-737, 1983

Racklin B, Bearman B, Sheibani K, Winberg CD,
Rappaport H: Identification of TdT by avidin-biotin
complex (ABC) technique. Leuk Res 7:431-437, 1983

Sheibani K, Forman S, Winberg CD, Rappaport 4H:
Coexistence of chronic lymphocytic ieukemia and
cutaneous T-cell lymphoma (mycosis fungoides). Blood
62:1176-1181, 1983

Sheibani K, Fritz R, Winberg CD, Burke J, Rappaport H:
Monocytoid cells in reactive follicular hyperplasia with
and without multifocal histiocytic reaction. An
immunohistochemical study of 21 cases including
suspected cases of toxoplasmic lymphadenitis. Am J Clin
Pathol 81:453-458, 1984

Battifora 4H, Sheibani_K, Tubbs RR, Kopinski MM:
Antikeratin antibodies in tumor diagnosis. Cancer
54:843-848, 198424.

25.

26.

27.

28.

29.

30.

31.

32.

33.

34,

35.

Khalil Sheibani, M.D.

Sheibani K, Tubbs R: Enzyme immunohistochemistry:
Technical aspects. Sem Diag Pathol 4:235-250, 1984

Tubbs R, Sheibani K: Immunohistology of
lymphoproliferative disorders. Sem Diag Pathol
4:272-284, 1984

Nathwani BN, Sheibani K, Winberg CD, Burke JS, Rappaport
HK: Neoplastic B-cells with cerebriform nuclei in
follicular lymphomas. Hum Pathol 16:173-180, 1985

Sheibani K, Nathwani BN, Winberg CD, Scott B, Teplitz R,
Rappaport H: Small lymphocytic lymphoma. Morphologic
and immunologic progression. Am J Clin Pathol
84:237-243, 1985

Sohn C, Sheibani K, Winberg CD, Rappaport H: Monecytoid
B-lymphocytes in AIDS-related lymphadenopathy. Hum
Pathol 16:979-985, 1985

Winberg C, Sheibani__K, Krance R, Rappaport H:
Peripheral T-cell Lymphoma: Immunologic and
cell-kinetic observations associated with morphological
progression. Blood 66:980-989, 1985

Sheibani K, Winberg CD, Burke JS, Rappaport He
Emmunophenotype of monocytoid b-lymphocytes. Am J Clin
Pathol 82:574, 1985 (letter)

Sheibani K, Battifora H: Leu-Ml positivity not specific
for Hodgkins disease. Am J Clin Pathol 84:682-683, 1985

Hsu SM, Yo YS, Monheit LJ, Ree HG, Sheibani K, Winberg
CD: L and H variants of Reed-Sternberg cells express
sialylated Leu-M1 antigen. Am J Pathol 122:199-203, 1986

Sheibani K, Battifora H, Winberg CD, Burke JS, Ben-Ezra
J, Ellinger JM, Quigley NJ, Fernandez BB, Morrow D,
Rappaport H: Further evidence that "malignant
angioendotheliomatosis" is an angiotropic large-cell
lymphoma. WN Engl J Med 314:943-948, 1986

Sheibani K, Winberg CD, Van DE Velde S, Williams J,

Rappaport H: Detection of lymphocyte antigens in
tissues placed in transport medium. An immunchistologic
study of 56 cases. Comparison with cryostat fresh

frozen technique. Am J Clin Pathol 85:297-304, 1986

Sheibani K, Battifora H, Burke JS, Rappaport H: Leu-M1
antigen in human neoplasms. An immunohistologic study
1836.

37.

38.

39.

40.

41.

42.

43.

44.

45.

Khalil Sheibani, M.D.
of 400 cases. Am J Surg Pathol 10:227-236, 1986

Sheibani_K, Battifora H, Burke JS: Antigenic phenotype
of malignant mesotheliomas and pulmonary adenocarcinoma.
An immunchistologic analysis demonstrating value of
Leu-Ml antigen. Am J Pathol 123:212-219, 1986

Burke JS, Sheibani_ kK, Rappaport, H: Dermatopathic
lymphadenopathy: An  Inmmologic study. Am J Pathol
123:256-263, 1986

Winberg CD, Krance R, Sheibani_ kK, Rappaport Hi:
Peripheral T-cell lymphoma: “A case report demonstrating
morphologic heterogeneity and progression and atypical
immune reactions. Cancer $7:2329-2342, 1986

Kokal W, Sheibani K, Terz J, Harada R: Tumor DNA
content aS a prognostic indicator in colorectal
carcinoma. JAMA 255:3123~3127, 1986

Sheibani K, Sohn CC, Burke JS, Winberg CD, Wu aM,
Rappaport H: Monocytoid B-cell lymphoma: A novel
B-cell neoplasm, Am J Pathol 124:310-318, 1986

Ben-Ezra J, Sheibani K, Kendrick F, Winberg CD,
Rappaport H: B-cell anglotropic (intravascular) large
cell lymphoma of the prostate gland. Hum Pathol
17:964-967, 1986

Sheibani K, Battifora H, Winberg CD, Burke J, Ben-Ezra
J, Rappaport H: Angiotropic large cell lymphoma, an
appropriate term for malignant angicendotheliosis. N
Engl J Med 315:895-896, 1986 (letter)

Knowles D, Neri A, Pelicci P-G, Burke JS, Wa aM, Winberg
CD, Sheibani K, Dalla-Favera R: Value of gene
rearrangement studies in diagnosis of Hodgkin's disease,
Proc Natl Acad Sci 83:7942-7946, 1986

Beatty J, Beatty B, Duda R, Sheibani K, Philben v,
Williams L, Paxton LE, Shively J: Preoperative imaging
of colorectal carcinoma with indium-111 labeled anti-CEA
monoclonal antibody. Cancer Res 46:6494-6502, 1986

Beatty B, Paxton R, Sheibani K, Williams L, Shively J,

Beatty D: Imaging of “normal testicular tissue with
IlI-indium labeled anti-CEA moneclonal antibodies:
Correlation with immunohistologic studies. Cancer Res

46:6503--6508, 1986

1946,

47.

48.

49,

50.

$1.

52.

53.

54.

55.

Khalil Sheibani, M.D.

Duda RB, Beatty DU, Sheibani K, Williams LE, Paxton RJ,
Betty BG,Shively CE:Imaging of humen colorectal
adenocarcinoma with INDACEA. Arch Surg 121:1310-1315,
1986

Kokal W, Duda RB, Azumi N, Sheibani_K, Kemeny M, Terz J:
Tumor ploidy in colorectal carcinoma. Arch Surg
121:1434-1439, 1986

Sheibani K, Winberg CD, Van DE Velde S, Biayney DB,

Rappaport 4H: Distribution interleukin-2 (TAC) antigen
in human lymphoproliferative disorders. An
immunohistologic study of 300 cases. Am J Pathol

127:27-37, 1987

Ben-Ezra J, Winberg CD, Wu AM, Sheibani K, Rappaport H:
Small lymphocytic lymphoma of lung: Concurrent
expression of two clonal populations. Hum Pathol
18:399-402, 1987

Churchill M, Zia J, Forman $, Sheibani K, Azumi N, Blume
K: Quantity of human cytomegalovirus DNA in lungs from
bone marrow transplant recipients with interstitial
pneumonia. J Infect Dis 155:501-509, 1987

Burke JS, Sheibani K, Winberg CD, Rappaport H: Value of
the immunchistologic studies in the diagnosis of hairy
cell leukemia in the spleen with normal weight. Am J
Clin Pathol 87:276-281, 1987

Sheibani K, Winberg CD, Burke JS, Nathwani BN, Blayney
DW, Van DE Velde S, Rappaport H: Lymphoblastic lymphoma
with natural killer cell phenotype: A clinicopathologic
study of six cases. Leuk Res 14:371-377, 1987

Burke J, Sheibani K: Hairy cell leukemia and monocytoid
B-cell lymphomas: Are they related? Leukemia
1:298-300, 1987

Sheibani K, Nathwani BN, Winberg CD, Burke JS, Blayney
5, Swartz W, Van DE Velde S, Rappaport Hi Antigenically
defined subgroups of lymphoblastic lymphoma: Their
relationship to clinical presentation and biclogic
behavior. Cancer 60:183-190, 1987

Ben-Ezra J, Sheibani  K: Antigenic phenotype of the
lymphocytic component of meduilary carcinoma of the
2056.

S?.

58.

59.

60.

61.

62.

63.

Khalil Sheibani, M.D.
breast. Cancer 59:2037-2041, 1987

Presant C, Gala K, Wiseman C, Kennedy P, Sheibani_ K,
Winberg CD: HTLV-IIl~-associated T-cell lymphoblastic
lymphoma in AIDS, Cancer 60:1459-1461, 1987

Brownell M, Sheibani K, Battifora H, Winberg CD,
Rappaport H: Differentiation between small noncleaved
cell and lymphoblastic lymphomas: A study of
paraffin-embedded fixed tissue sections using monoclonal
antibodies. Am J Surg Pathol 11:779-787, 1987

Sheibani K, Winberg CD: A systematic approach for the
immunohistologic classification of lymphoproliferative
disorders. Hum Pathol 18:1051-1062, 1987

Sheibani K, Wu AM, Ben-Ezra J, Stroup R, Rappaport H,
Winberg CD: Rearrangement of kappa light chain and T
cell receptor b chain genes in malignant lymphoma of
"T-cell" phenotype. Am J Pathol 129:201-207, 1987

Burke J, Sheibani K, Nathwani BN, Winberg CD, Rappaport
H: Monoclonal small (well-differentiated) lymphocytic
infiltrates of the gastrointestinal tract resembling
lymphoid hyperplasia. A neoplasm of uncertain malignant
potential. Hum Pathol 18:1238-1245, 1987

Philben V, Beatty D, Beatty 8, Williams L, Paxton R,
Sheibani K: Imaging of colon carcinoma with 111-indium
Tabeled anti-CBA monoclonal antibody {(INDACEA). Arch
Surg 122:1333-1337, 1987

Beatty JD, Duda RB, Beatty BG, Paxton RJ, Shively JE,
Williams LE, Sheibani_K, Valahos WG, Werner JL, Kekal

WA, Riihimaki RV, Terz Jd, Wagman LD: Imaging of
colorectal carcinoma with INDACEA (Indium labeled
anti-CEA monoclonal antibody}. In: Clinical Immunology
W. Pruganski and M. Seligmann, Eds. Elsevier Science

Publisher. pp 287-292, 1987

Ratech H, SheibaniK, Nathwani BN, Rappaport 4H:

Immunoarchitecture of the "pseudofollicles" of
well-differentiated (small) lymphocytic lymphoma: A
comparison with true follicies. Hur Pathol 19:89-94,
1988

2164.

65.

66.

68.

69.

70.

71.

72,

73.

74.

Khalil Sheibani, M.D.

Sheibani K, Battifora H: Signet-ring cell melanoma: A
rare morphologic variant of malignant melanoma. An J
Surg Pathol 12:28-34, 1988

Santamaria M, Llamas L, Ree HJ, Sheibani_ K, Ho YS, Su
iJ, Hsu SM: Expression of sialylated Leu-Ml antigen in
histiocytosis X. Am J Clin Pathol 89:211-216, 1988

Sheibani K, Nathwani BN, Swartz W, Ben-Ezra J, Brownell
M, Burke J, Kennedy J, Koo C, Winberg CD: Variability
in interpretation of immunohistologic findings of
liymphoproliferative disorders by hematopathologists: A
comprehensive statistical analysis of interobserver
performance. Cancer 62:657-664, 1988

Sheibani K, Burke J, Swartz W, Nademanee A, Winberg CD:
Monocytoid B cell lymphoma: Clinicopathologic study of
2l cases of a unique type of low grade Lymphoma. Cancer
62:1531-1538, 1988

Winberg CD, Sheibani K, Burke JS, Stroup R, Rappaport H:

T-cell-rich lymphoproliferative disorders: Morphologic
and  immunclogic differential diagnoses. Cancer
62:1539-1555, 1988

Traweek ST, Winberg CD, Sheibani K: Monocytoid B-cell
Lymphoma : Point on a spectrum. Am J Clin Pathol
90:748, 1988 (letter)

Kokal W, Gardine R, Sheibani K, Zak IW, Beatty DJ,
Rilhimaki DU, Wagman LD, Terz J, Harada R: Tumor DNA
Content as a prognostic indicator in squamous cell
carcinoma of head and neck regions. Am J Surg
156:276-280, 1988

Azumi N, Sheibani K, Swartz W, Stroup R, Rappaport H:
Antigenic phenotype of Langerhans cell histiocytosis:
An immunchistologic study demonstrating the value of
LN2, LN3, and vimentin. Hum Pathol 19:1376-1382, 1988

Ben-Ezra J, Wu AM, Sheibani  K: Absence of
immunoglobulin gene rearrangement in Hashimoto's
thyroiditis. Hum Pathol 19:1444-1448, 1988

Sheibani  K: Signet-ring cell melanoma. A rare
morphologic variant of malignant melanoma. Am J Surg
Path 12:28-34, 1988

Dennis TR, Stock DA, Winberg CD, Sheibani K, Rappaport:
2275.

76.

77.

78.

79.

80.

gl.

82.

83.

Khalil Sheibani, M.D.

Cytogenetic Studies of Hodgkin's Disease: Analysis of
involved lymph nodes from 12 patients. Cancer Genet
Cytogenet 37:201-208, 1989

Sheibani K, Traweek ST, Ben-Ezra J, Stroup R, Esteban J,
Rappaport H, Battifora H, Forman 8, Doroshow J, Niland
J:  Monocytoid B-cell lymphoma. Am J Surg Path Vol. 13:
902-904

Kokal W, Gardine R, Sheibani K, Terz J: Diagnostic and
prognostic value of évaluations of tumor DNA in colon
carcinomas. Annals Surg 209:188-192, 1989

Traweek ST, Sheibani K, Winberg CD, Wu AM, Rappaport H:
Monecytoid “B-cell lymphoma: Tts evolution and
distinction from other B-cell neoplasms. Blood
73:573-578, 1989

Ratech H, Burke JS, Blayney DW, Sheibani_ K, Rappaport H:
A clinicopathologic study of malignant lymphomas of the
nose, paranasal sinuses and hard palate including cases
of so-called “lethal midline granuioma”. Cancer
64:2525-2531, 1989

Ben-Ezra J, Sheibani_ K, Stroup R, Traweek ST, Kezirian
gd, Swartz, W: Correlation of intensely of eosinophilia
and immunologic phenotype in Hodgkin's disease. Human.
Pathol 20:1181-1185, 1985

Wu AM, Winberg CD, Sheibani K, Colombero AM, Wallace B,

Rappaport H: Genotype and phenotype: A practical
approach to the immunogenetic analysis of
lymphoproliferative disorders. Human Pathol 21:1132-
Ll4i, 1990

Stroup RM, Sheibani K, Misset Jk, Szekely AM, Tremblay G
Rappaport, H: Surface immunoglobulin positive
lymphoblastic lymphoma. A report ef three cases.Cancer
65:2559-2563, 1990

Koo CH, Mason DY, Miller R, Ben-Ezra J, Sheibani_ K,
Rappaport H: Further evidence that "plasmacytoid T-cell
lymphoma” associated with chronic myelogenous leukemia
is of macrophage/mononuclear origin. Am J Clin Pathol
93:822-827, 1990

Sheibani K, ‘Traweek T, Shin S, Ben-Ezra J, Stroup R,
Esteban J, Rappaport H, Battifora H: Monocytoid B-cell
2384.

BS.

86.

87.

88.

89.

30.

gl.

92.

93.

Khalil Sheibani, M.D.

lymphoma is not a MALT-associated lymphoma. Am J Surg
Pathol 14:890-890, 1990

Sheibani K, Ben-Fzra J, Swartz W, Rossi J, Kezirian J
Winberg CD: Occurrence of monocytoid B-cell lymphoma in
a patient with acquired immune deficiency syndrome:
Demonstration of HIV genome in paraffin sections.
Archives of Patholo Lab Med 114:1264-1267, 1990

Stroup R, Sheibani_K, Moncada A, Purdy J, Battifora H:
Angiotropic large cell lymphoma: Clinicopathologic
study of seven cases with unique clinical presentation.
Cancer 66(11):2559-2563, 1990

Ben-Ezra J, Sheibani K, Lev-Ran R: Megakaryocyte
synthesis is the source of epidermal growth factor (EGF
in human platelets. Am J Pathol 137:755-759, 1990

Esteban J, Sheibani_ K, Reilly M, Owens M, Battifora H:
Effect of tissue fixation in ploidy analyses. Am J Clin
Pathol 95:460-466, 1990

Ben-Ezra J, Bailey A, Azumi N, Stroup R, Sheibani_K,
Rappaport H: Malignant histiocytosis X-a distinct
clinicopathologic entity. Cancer 68:1050-1060, 1991

Mohram R, Brynes R, Nathwani BN, Sheibani K: Hodgkin's
disease occurring in monocytoid B-cell clusters. Am J
Clin Pathol 95:802-808, 1931

Shin S, Sheibani_ K, Fishleder A, Ben Ezra J, Bailey A,
Koo C, Burke J, Tubbs R, Rappaport H,: Monocytoid B-cell
lymphoma in patients with Siogren’s Syndrome. A
clinicopathologic study of thirteen patients. Hum Pathol
22:422-429, 1991

Sheibani K, Shin 5,Kezirian J,Weis L: The Ber-Ep4
antibody as a discriminant in the differential diagnosis

of mesothelioma vs adenocarcinoma. Am J Surg Pathol
15:779-785, 1991

Traweek T, Sheibani_ K: Monocytoid B cell Lymphoma: The
biologic and clinical implications of peripheral blood
involvement. Am J Clin Pathol 97:591-598, 1992

Stroup RM, Burke J, Sheibani_ K, Ben-Ezra J, Winberg C:
Splenic involvement by aggressive malignant lymphoma of
B and Tf cell type: A morphologic and immunophenotypic
study. Cancer 69:413-420, 1992

2494.

95.

96.

37.

o8.

99.

100.

101.

102.

103.

104.

Khalil Sheibani, M.D.

Stroup R, Sheibani K: Hairy-cell leukemia and
monocytoid B-cell Lymphoma: An immunchistologic
comparison of 66 cases. Human Pathol 23:172-177
1992

Nathwani B, Mohrmann RL, Brynes RK, Taylor CR, Hansmann
ML, Sheibani  K: Monocytoid B-cell lymphomas: An
assessment of diagnostic criteria and a perspective on
histogenesis. Human Pathol 23:1061-1071, 1992

Esteban JM, Sheibani_K: DNA ploidy analysis of pleural
mesotheliomas: its usefulness for their distinction from
lung adenocarcinomas. Modern Pathol 5:626-630, 1992

Shin SS, Sheibani_ K, Kezirian 3, Nademanee A, Forman S:
Immuncarchitecture of normal human bone marrow. Human
Pathol 23:686-694, 1992

Sheibani K, Esteban OM, Daily A. Weiss Le
Tmmunopathologic and Molecular Studies as an aid to the
diagnosis of malignant mesothelioma. Human Pathol

23:107-116,1992

Shin SS, Sheibani_ K: Monocytoid B-cell lymphoma. Am J
Clin Pathol 99:421-425, 1993

Shin SS, Sheibani K, Kezirian J, Winberg CD: Trmuno-
histologic study of lymphoproliferative disorders in
bone marrow frozen sections. An analysis of 42 cases.

Human Pathol 24:30-36, 1993

Shin SS, Sheibani K, Kezirian J, Winberg C: Immuno-
histologic studies of bone marrow on frozen sections: An
analysis of 42 cases. Human Pathol 24:30-36, 1993

Shin S5, Sheibani K:Monocytoid B cell Lymphoma. Amer J
Clin Pathol 99:421-425, 1993

Shin S,Ben-Ezra J, Burke J, Sheibani_ K, Rappaport H:
Reed-Sternberg-like cells in low grade lymphoma are
transformed neoplastic cells of B-cell lineage. Am J
Clin Pathol 99:658-662, 1993

Erber DA, Sheibani K, Weiss L M: UCL3D3 and UCL4D12
Reactivity in small B-cell neoplasm with special
emphasis on monocytoid B-cell lymphoma. Hum Pathol

25:1084-1090, 1994

105.

Parker P, Chao N, Ben-Ezra 3, Slatkin N, Openshaw H,
Niland J, Linker C, Greffe B, Kashyap A, Molina A,
25106,

Khalil Sheibani, M.D.

Nademanee A, O'Donnell M, Planas I, Sheibani K, Smith

E, Snyder DB, Spielberger R, Stein A, Stepan D, Blume K,
Forman S: Polymyositis as a Manifestation of Chronic
Graft-Versus-Host Disease. Medicine Vol 75, No. 5 279-
285, 1996

Nathwani BN, Dranchenberg Mr, Hernandez AM, Sheibani K:
Monocytoid B-cell lymphoma (Nodal Marginal-dZone B-Cell
Lymphoma). Seminars in Hematclogy 36:128-138, 1999

II. BOOK CHAPTERS AND MONOGRAPHS:

107.

108.

109.

110.

112.

Koo C, Rappaport H, Sheibani K, Nathwani BN, Winberg CD:

Significance of imprint in diagnosis of non-Hodgkin's
lymphoma. Human Pathol. Monograph. Human Pathol,
1-137, 1989

Sheibani K: Enzyme immunchistochemistry: Review of

theoretical principles, technical aspects, and clinical
application. In Neoplastic Hematopathology. Knowles D.
Edit. Williams and Wilkins, publisher. pp. 197-213, 1992

Sheibani_ K: Monocytoid B-cell lymphoma: Review of
morphologic,